Camie Nakagawa-Kakuda, OD
Optometrist · Waipahu, HINPI 1366015562
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,295 of the $7,335 with a category attached, or 72.2%. 16 manufacturers reported payments, led by Alcon at 37.3% of the total. Reporting peaked in 2022 at $3,411 and has fallen 75.2% since, to $847 in 2025. Among optometrist clinicians in HI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 99 payments — averaging $74.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$3K
- Bausch & Lomb Americas Inc.$977
- Johnson & Johnson Surgical Vision, Inc.$732
- AbbVie$534
- Bausch & Lomb, A Division Of Bausch Health US, LLC$487
- Tarsus Pharmaceuticals, Inc.$387
- plus $1K from 10 others
What the payments were for
- Travel & lodging$1,91126%
- Food & beverage$5,29572%
- Entertainment$1292%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 31 | $2,733 |
| Bausch & Lomb Americas Inc. | 13 | $977 |
| Johnson & Johnson Surgical Vision, Inc. | 8 | $732 |
| AbbVie(2 entities) | 9 | $534 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $487 |
| Tarsus Pharmaceuticals, Inc. | 9 | $387 |
| Amgen(2 entities) | 5 | $353 |
| Coopervision Inc. | 8 | $291 |
| Glaukos Corporation | 1 | $142 |
| Optos, Inc. | 2 | $129 |
| Johnson & Johnson Vision Care, Inc. | 2 | $128 |
| Dompe US, Inc. | 1 | $125 |
| LKC Technologies, Inc. | 1 | $121 |
| Sight Sciences, Inc. | 1 | $117 |
| Kala Pharmaceuticals, Inc. | 3 | $55 |
| Novartis | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAILIES TOTAL1 Multifocal$1,734
- AIR OPTIX$1,734
- Dailies Aqua Comfort Plus$1,734
- INFUSE$795
- BIOTRUE ONE DAY$562
- LIPIFLOW SYSTEM ACTIVATOR (DISPOSABLE)$429
- TOTAL30$400
- XDEMVY$269
- Tecnis IOL$235
- VUITY$218
- ZEN LENS$150
- ULTRA MULTIFOCAL TORIC$148
- iStent Trabecular Micro-Bypass System Model iS3$142
- TEPEZZA$140
- VYZULTA$125
- Oxervate$125
- LUMIGAN$125
- COMBIGAN$125
- DAILIES$122
- CATALYS SYSTEM$117
How this compares
$7,335 in reported general payments places this provider in the 90th percentile of 310 optometrist providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MieboPerfluorohexyloctane/Pf | 17 | $12,828 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb Americas Inc.Miebo | $977 | $12,82817 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 310 optometrist providers in Hawaii.
Other optometrist in Waipahu
- Jon IshiharaWaipahu$13K
- Kathy IshimotoWaipahu$8K
- Linda ArakakiWaipahu$6K
- Darrah WongWaipahu$5K
- Natalie RamirezWaipahu$4K
- Grant MiyashiroHilo$26K
- Jana SouzaHilo$16K
- Geoffrey ReynoldsMililani$14K
- Patricia IchimuraHonolulu$11K
- Lillian TakamuraHonolulu$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.